Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:ACKNOWLEDGEMENTS TO REVIEWERS
Volume: 16 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, ACKNOWLEDGEMENTS TO REVIEWERS, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2016; 16 (3) . https://dx.doi.org/10.2174/187152221603170706164957
DOI https://dx.doi.org/10.2174/187152221603170706164957 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
12
Related Articles
-
Wound with Diabetes: Present Scenario and Future
Current Diabetes Reviews Glucocorticoid Measurements in Health and Disease - Metabolic Implications and the Potential of 24-h Urine Analyses
Mini-Reviews in Medicinal Chemistry A Comprehensive Review of Alzheimer’s Association with Related Proteins: Pathological Role and Therapeutic Significance
Current Neuropharmacology Effects of Brain IKKβ Gene Silencing by Small Interfering RNA on P-Glycoprotein Expression and Brain Damage in the Rat Kainic Acid-Induced Seizure Model
CNS & Neurological Disorders - Drug Targets The Use of Herbal Medicine in Cancer-related Anorexia/ Cachexia Treatment Around the World
Current Pharmaceutical Design Intracellular Location of KATP Channels and Sulphonylurea Receptors in the Pancreatic β-cell: New Targets for Oral Antidiabetic Agents
Current Medicinal Chemistry Patent Selections:
Recent Patents on Cardiovascular Drug Discovery New Chemotherapeutic Strategies Against Malaria, Leishmaniasis and Trypanosomiases
Current Medicinal Chemistry Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice
Current Medicinal Chemistry Chitin-like Polysaccharides in Alzheimers Disease Brains
Current Alzheimer Research Mesenchymal Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus
Current Stem Cell Research & Therapy Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Current Pharmaceutical Design Sorting Mechanism of Peptide Hormones and Biogenesis Mechanism of Secretory Granules by Secretogranin III, a Cholesterol-Binding Protein, in Endocrine Cells
Current Diabetes Reviews Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Gut Inflammation in Response to Injury: Potential Target for Therapeutic Intervention
Recent Patents on Anti-Infective Drug Discovery Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry Metformin Beyond Diabetes: New Life for an Old Drug
Current Diabetes Reviews Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design